WellCare Health Plans (WCG) Tops Q4 EPS by 7c, Revenues Beat; Raises FY19 EPS Guidance
WellCare Health Plans (NYSE: WCG) reported Q4 EPS of $1.63, $0.07 better than the analyst estimate of $1.56. Revenue for the quarter came in at $5.94 billion versus the consensus estimate of $5.83 billion.
"While our recent focus has been on 2019 and beyond, we are pleased to report a strong finish to 2018, a year with multiple Medicaid RFP wins and the closing of two meaningful acquisitions," said Ken Burdick, WellCare's chief executive officer. "We are excited that we were able to capitalize on opportunities that will provide continued revenue and earnings growth over the next few years."
"Based upon our strong finish to 2018 and better than expected membership growth in our Medicare PDP segment, we are increasing our full-year 2019 adjusted earnings per diluted share guidance to a range of $13.25 to $13.50," continued Burdick.
GUIDANCE:
WellCare Health Plans sees FY2019 EPS of $13.25-$13.50, versus the consensus of $13.47.
WellCare is increasing its full-year 2019 adjusted EPS guidance to a range of $13.25 to $13.50 from its previous guidance range of $13.15 to $13.40 per diluted share. Refer to the appendix in this news release for specific 2019 guidance metrics, related footnotes and basis of presentation.
For earnings history and earnings-related data on WellCare Health Plans (WCG) click here.
